Research ArticleCLINICAL INVESTIGATIONS
Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study
Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, Gerlinde Egerer, Julie Vasamiliette, Gunhild Mechtersheimer, Thomas Schmitt, Burkhard Lehner, Uwe Haberkorn, Philipp Stroebel and Bernd Kasper
Journal of Nuclear Medicine April 2010, 51 (4) 551-558; DOI: https://doi.org/10.2967/jnumed.109.070862
Antonia Dimitrakopoulou-Strauss
Ludwig G. Strauss
Gerlinde Egerer
Julie Vasamiliette
Gunhild Mechtersheimer
Thomas Schmitt
Burkhard Lehner
Uwe Haberkorn
Philipp Stroebel

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 51, Issue 4
April 2010
Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study
Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, Gerlinde Egerer, Julie Vasamiliette, Gunhild Mechtersheimer, Thomas Schmitt, Burkhard Lehner, Uwe Haberkorn, Philipp Stroebel, Bernd Kasper
Journal of Nuclear Medicine Apr 2010, 51 (4) 551-558; DOI: 10.2967/jnumed.109.070862
Impact of Dynamic 18F-FDG PET on the Early Prediction of Therapy Outcome in Patients with High-Risk Soft-Tissue Sarcomas After Neoadjuvant Chemotherapy: A Feasibility Study
Antonia Dimitrakopoulou-Strauss, Ludwig G. Strauss, Gerlinde Egerer, Julie Vasamiliette, Gunhild Mechtersheimer, Thomas Schmitt, Burkhard Lehner, Uwe Haberkorn, Philipp Stroebel, Bernd Kasper
Journal of Nuclear Medicine Apr 2010, 51 (4) 551-558; DOI: 10.2967/jnumed.109.070862
Jump to section
Related Articles
Cited By...
- Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)
- PET Response Criteria in Solid Tumors Predicts Progression-Free Survival and Time to Local or Distant Progression After Chemotherapy with Regional Hyperthermia for Soft-Tissue Sarcoma
- Sarcoma Mid-Therapy [F-18]Fluorodeoxyglucose Positron Emission Tomography (FDG PET) and Patient Outcome
- Evaluation of the Genisys4, a Bench-Top Preclinical PET Scanner
- Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT
- 18F-FDG-PET/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy
- Shortened Acquisition Protocols for the Quantitative Assessment of the 2-Tissue-Compartment Model Using Dynamic PET/CT 18F-FDG Studies